Identification |
Name: | 2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]- |
Synonyms: | 4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propyloxy]-6-[(vinylcarbonyl)amino]quinazoline;Cl 1033;N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide; |
CAS: | 267243-28-7 |
Molecular Formula: | C24H25ClFN5O3 |
Molecular Weight: | 485.9384 |
InChI: | InChI=1/C23H23ClFN5O3/c1-2-22(31)29-20-12-16-19(13-21(20)33-10-7-30-5-8-32-9-6-30)26-14-27-23(16)28-15-3-4-18(25)17(24)11-15/h2-4,11-14H,1,5-10H2,(H,29,31)(H,26,27,28) |
Molecular Structure: |
![(C24H25ClFN5O3) 4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propyloxy]-6-[(vinylcarbonyl)amino]quinazoli...](https://img1.guidechem.com/chem/e/dict/23/267243-28-7.jpg) |
Properties |
Density: | 1.355 g/cm3 |
Refractive index: | 1.659 |
Appearance: | white or similar to white crystalline powder |
Usage: | Antineoplastic; irreversible pan-erbB tyrosine kinase inhibitor used to treat cancer. |
Safety Data |
|
 |